A DeepMind Spinout Just Raised $5 Billion, Biotech's Biggest Venture Round Ever
Isomorphic Labs, Google DeepMind's drug-design spinout, raised a $5 billion Series C, biotech's biggest venture round ever, with no drug yet in human trials.

Speaking-first app with an AI tutor, video lessons, roleplays and pronunciation coaching
Speak is built around talking: short video lessons teach phrases, you drill them aloud, then use them in back-and-forth conversation with the Speak Tutor. It teaches Spanish, French, Korean, Japanese, Italian and Mandarin to English speakers, plus English for learners worldwide, and is backed by the OpenAI Startup Fund.
The most polished speaking practice in the category, but pricier than most and phone-only.
See all Speak alternatives, ranked →
Duolingo vs SpeakSpeak vs BabbelSpeak vs Busuu
Thanks! We'll check it against official sources and update the listing if it's confirmed.
Isomorphic Labs, Google DeepMind's drug-design spinout, raised a $5 billion Series C, biotech's biggest venture round ever, with no drug yet in human trials.
Swiss biotech Nouscom raised €120M ($135M) on Oct 19, 2026 for a pivotal trial of NOUS-209, an off-the-shelf vaccine to prevent cancer in Lynch syndrome carriers.
Intel just sold $20 billion of stock at $95 a share — a year after the U.S. government bought in at $20.47. Inside the raise, the comeback bet, and the catch.